On Monday, Agilon Health Inc (NYSE: AGL) was -1.11% drop from the session before settling in for the closing price of $2.70. A 52-week range for AGL has been $2.36 – $17.52.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 53.71%. When this article was written, the company’s average yearly earnings per share was at 25.75%. With a float of $302.82 million, this company’s outstanding shares have now reached $406.39 million.
Let’s determine the extent of company efficiency that accounts for 1117 employees. In terms of profitability, gross margin is 0.49%, operating margin of -4.86%, and the pretax margin is -4.19%.
Agilon Health Inc (AGL) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Agilon Health Inc stocks. The insider ownership of Agilon Health Inc is 26.41%, while institutional ownership is 86.94%. The most recent insider transaction that took place on Sep 12 ’24, was worth 67,188. In this transaction CEO & President of this company bought 20,000 shares at a rate of $3.36, taking the stock ownership to the 67,590 shares. Before that another transaction happened on Nov 29 ’23, when Company’s Director bought 22,300 for $11.22, making the entire transaction worth $250,206. This insider now owns 31,931 shares in total.
Agilon Health Inc (AGL) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.08 earnings per share (EPS) during the time that was less than consensus figure (set at -0.06) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 25.75% per share during the next fiscal year.
Agilon Health Inc (NYSE: AGL) Trading Performance Indicators
You can see what Agilon Health Inc (AGL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.62, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.16 in one year’s time.
Technical Analysis of Agilon Health Inc (AGL)
Looking closely at Agilon Health Inc (NYSE: AGL), its last 5-days average volume was 3.64 million, which is a drop from its year-to-date volume of 4.89 million. As of the previous 9 days, the stock’s Stochastic %D was 52.98%. Additionally, its Average True Range was 0.25.
During the past 100 days, Agilon Health Inc’s (AGL) raw stochastic average was set at 5.86%, which indicates a significant decrease from 27.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 69.03% in the past 14 days, which was lower than the 77.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.40, while its 200-day Moving Average is $5.28. However, in the short run, Agilon Health Inc’s stock first resistance to watch stands at $2.76. Second resistance stands at $2.84. The third major resistance level sits at $2.94. If the price goes on to break the first support level at $2.58, it is likely to go to the next support level at $2.48. Should the price break the second support level, the third support level stands at $2.40.
Agilon Health Inc (NYSE: AGL) Key Stats
There are 411,483K outstanding shares of the company, which has a market capitalization of 1.16 billion. As of now, sales total 4,316 M while income totals -262,600 K. Its latest quarter income was 1,483 M while its last quarter net income were -30,680 K.
